Product Information
KAZANO 12.5-1,000 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.5654 per EA under NDC 64764033760. Its NADAC has been published 562 times since Dec 18, 2013.
FDA first approved this application on Jan 25, 2013.
Strength
12.5; 1000 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764033760
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/22/2025
Active Ingredients
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA203414FDA Approved
1/25/2013
On Market Since
1/25/2013
Pharmacological Classes
Price Statistics
The NADAC for KAZANO 12.5-1,000 MG TABLET has been published 562 times since Dec 18, 2013, and over the history we have for it it has risen 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5654 per EA |
|---|---|
| All-time high | $6.5877 (Aug 14, 2024) |
| All-time low | $4.1318 (Dec 18, 2013) |
| 52-week high | $6.5654 |
| 52-week low | $6.5654 |
| Median price | $6.1767 |
| Average price | $6.0114 |
| Largest weekly change | +9.9% (Aug 12, 2015) |
| Weeks tracked | 562 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+0.1%
5Y
+0.3%
All
+58.9%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KAZANO 12.5-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KAZANO 12.5-1,000 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $6.5654 per EA (NDC 64764033760), effective Jan 14, 2026.
How has the price of KAZANO 12.5-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for KAZANO 12.5-1,000 MG TABLET has risen 58.9%. It has been tracked across 562 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for KAZANO 12.5-1,000 MG TABLET?
Since Dec 18, 2013, the NADAC for KAZANO 12.5-1,000 MG TABLET has ranged from a low of $4.1318 (Dec 18, 2013) to a high of $6.5877 (Aug 14, 2024), with a median of $6.1767 per EA.
Are there cheaper alternatives to KAZANO 12.5-1,000 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALOGLIPTIN-METFORMIN 12.5-1000, is $2.4942 per EA — about 62% below KAZANO 12.5-1,000 MG TABLET.
Who manufactures KAZANO 12.5-1,000 MG TABLET?
KAZANO 12.5-1,000 MG TABLET (NDC 64764033760) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.